Both oxidative and nitrosative stress are associated with muscle wasting in tumour-bearing rats.
about
Cancer cachexia--pathophysiology and managementUnderstanding the "lethal" drivers of tumor-stroma co-evolution: emerging role(s) for hypoxia, oxidative stress and autophagy/mitophagy in the tumor micro-environmentLoss of muscle mass: current developments in cachexia and sarcopenia focused on biomarkers and treatmentSkeletal muscle myofilament adaptations to aging, disease, and disuse and their effects on whole muscle performance in older adult humansThe Janus-Faced Role of Antioxidants in Cancer Cachexia: New Insights on the Established ConceptsCancer cachexia: impact, mechanisms and emerging treatmentsEicosapentaenoic acid and oxypurinol in the treatment of muscle wasting in a mouse model of cancer cachexiaUCP3 in muscle wasting, a role in modulating lipotoxicity?Protein carbonylation and muscle function in COPD and other conditions.PGC-1α promotes nitric oxide antioxidant defenses and inhibits FOXO signaling against cardiac cachexia in mice.Fiber type-specific nitric oxide protects oxidative myofibers against cachectic stimuliThe cachexia score (CASCO): a new tool for staging cachectic cancer patients.Muscle oxidative capacity during IL-6-dependent cancer cachexia.Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training.Semi-automated image analysis: detecting carbonylation in subcellular regions of skeletal muscle.Cancer cachexia update in head and neck cancer: Pathophysiology and treatment.Decreased NADPH oxidase expression and antioxidant activity in cachectic skeletal muscle.Daily consumption of ready-to-use peanut-based therapeutic food increased fat free mass, improved anemic status but has no impact on the zinc status of people living with HIV/AIDS: a randomized controlled trialMolecular mechanisms underlying skeletal muscle weakness in human cancer: reduced myosin-actin cross-bridge formation and kinetics.Protein carbonylation, mitochondrial dysfunction, and insulin resistance.The emerging role of skeletal muscle oxidative metabolism as a biological target and cellular regulator of cancer-induced muscle wastingCancer cachexia prevention via physical exercise: molecular mechanisms.Metabolic derangements in the gastrocnemius and the effect of Compound A therapy in a murine model of cancer cachexiaRole of Protein Carbonylation in Skeletal Muscle Mass Loss Associated with Chronic ConditionsThe autophagic tumor stroma model of cancer or "battery-operated tumor growth": A simple solution to the autophagy paradox.l-carnitine and cancer cachexia: Clinical and experimental aspects.Antagonistic effects of acetylshikonin on LPS-induced NO and PGE2 production in BV2 microglial cells via inhibition of ROS/PI3K/Akt-mediated NF-κB signaling and activation of Nrf2-dependent HO-1.Sialic acid deficiency is associated with oxidative stress leading to muscle atrophy and weakness in GNE myopathy.Pharmacological strategies in lung cancer-induced cachexia: effects on muscle proteolysis, autophagy, structure, and weakness.Targeted overexpression of mitochondrial catalase protects against cancer chemotherapy-induced skeletal muscle dysfunction.Disrupted Skeletal Muscle Mitochondrial Dynamics, Mitophagy, and Biogenesis during Cancer Cachexia: A Role for Inflammation.Disruption of pro-oxidant and antioxidant systems with elevated expression of the ubiquitin proteosome system in the cachectic heart muscle of nude mice.Protein thiol oxidation does not change in skeletal muscles of aging female mice.UCP3 overexpression neutralizes oxidative stress rather than nitrosative stress in mouse myotubes.Mitochondrial dysfunction and therapeutic approaches in respiratory and limb muscles of cancer cachectic mice.Role of oxidative tissue injury in the pathophysiology of experimentally induced equine laminitis: a comparison of 2 models.Role of amino acids in rheumatoid arthritis studied by metabolomics.Role of Oxidative Stress as Key Regulator of Muscle Wasting during Cachexia.The AMPK agonist 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR), but not metformin, prevents inflammation-associated cachectic muscle wasting.
P2860
Q24605567-B15D3835-20C6-4B6C-8EB6-AE855DAF623CQ24620228-58882C5D-0FDA-44A7-8F14-20E7F33B77C5Q26775254-DA6931F2-D93B-4D8E-8348-A38E48A6AFB8Q27026517-EE12735B-BC36-4ACC-9978-2505394B1B3CQ28078802-9093B2F4-E20B-44C0-9ED8-6B99DB52E184Q28384479-36F7B168-7883-45E2-9F48-0B63261E90A1Q28483912-8F01F8C8-C869-4C8A-ADE0-AC2D53083948Q28568690-4E1EC01D-0041-4CB6-9B69-5B825E54B26DQ30354982-8AF622E6-0245-481C-9AF9-E3E1B2501190Q30427538-2EDAEE35-5593-4676-98E9-C13A580D0CE0Q33332170-9BDA8F58-A1EF-487B-B489-815B6D892FD0Q34201322-6FC9C35F-0AA9-4CF3-8552-83A870AAB4C9Q34598672-CA16AC8F-9DFD-4EBF-A3F9-B1A69D81C4BFQ34697114-220AF083-BAEB-4128-B549-DF5183B1BA8BQ34731705-ECA66A57-F33D-4B52-AA5C-0BC637E55C27Q35122201-3F1E8238-C63F-4C7E-BB28-671F4AFF2DF6Q35223974-7B9B1B7B-7724-450E-8FED-F799C3D57D77Q35884663-11C66554-F831-43A8-995A-AF18398F36FFQ36787452-EF9CC185-1CFA-4789-B191-F9904AF3097CQ36829659-9FF31C31-DD14-4A8E-83CE-C1CA8A206E4AQ36901945-B3B96E73-B99E-4435-9070-3023AFB0DDECQ36934986-BD7D75B6-7F39-478D-ADF6-6DC48611BB98Q36934990-9008EDCC-CDD1-4EE3-8822-BB66107B7A93Q37566391-DC80C224-D7CF-4741-BA9A-A2875F040E99Q37807243-ED501D4F-F1EB-475D-8F5C-69DAE0B6CCFFQ37863019-4785E585-B99C-4DA1-98F2-6905008BA1ADQ38425017-E552C60F-B626-4C7E-8CB8-B43FFE6D1EC1Q38785817-BAD56B45-D319-4659-B02E-36DC08481B09Q39016673-F50227A7-D2A2-4F7B-9825-E2EA6C060F66Q40982094-DB931993-4299-4751-A37E-7ED5574F5148Q41146515-0EF5BAEA-21FB-4B4D-911B-6F36D3D4B0CEQ41874017-C89A1CB2-8E05-4ADE-8E9D-F69010E1959EQ43590360-B1698376-6A0F-4FE5-8632-EF38FAC2FCF3Q46187034-0F4A265E-FFE6-4C00-B52A-603FF1166D08Q51033534-DBA004E4-02E6-4999-B46D-8EB0D5F14A19Q51878895-3019E083-E018-43E4-9B85-4496807B5E5EQ52698393-7D50FDA7-F12A-429B-8203-A505E0EAF805Q55383187-83F20CD8-8308-4291-856A-5385AD7E38EEQ55653938-68705CF6-1220-4469-821B-5D32AD401BFA
P2860
Both oxidative and nitrosative stress are associated with muscle wasting in tumour-bearing rats.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Both oxidative and nitrosative ...... asting in tumour-bearing rats.
@en
Both oxidative and nitrosative ...... asting in tumour-bearing rats.
@nl
type
label
Both oxidative and nitrosative ...... asting in tumour-bearing rats.
@en
Both oxidative and nitrosative ...... asting in tumour-bearing rats.
@nl
prefLabel
Both oxidative and nitrosative ...... asting in tumour-bearing rats.
@en
Both oxidative and nitrosative ...... asting in tumour-bearing rats.
@nl
P2093
P2860
P1433
P1476
Both oxidative and nitrosative ...... asting in tumour-bearing rats.
@en
P2093
Beatriz de la Puente
Esther Barreiro
Francisco J López-Soriano
Joaquim Gea
Josep M Argilés
P2860
P304
P356
10.1016/J.FEBSLET.2005.02.017
P407
P577
2005-03-01T00:00:00Z